Novartis's Cosentyx Fails To EXCEED Humira in PsA

'Narrowly Missed' Statistical Significance

 
• By Kevin Grogan
Fencing
Mixed results from Cosentyx and Humira head-to-head • Source: Shutterstock

More from Clinical Trials

More from R&D